维普中文期刊产品整合服务
105篇 您的检索式:作者名="Wassmann B"
    题名 作者 年代 出处 被引量
1Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme,a reductase inhibition,on coronary endothelial function显示文摘Wassmann S Faul A Hennen B 2003Circ Res2003,93,9:1
2Rapid effect of 3- hydroxy-3-methyl glutaryl coenzyme a reductase inhibition on coronary endothelial function 显示文摘Wassmann S Faul A Hennen B 2003Circ Res2003,93,9:1
3Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia显示文摘Ottmann OG Wassmann B 2005Hematology Am Soc Hematol Edue Program2005,21,2:1
4Imatinib compared with chemotherapy as frontline treatment of elderly patients with Philadelphia chromosomepositive acute lymphoblastic leukemia (Ph+ALL) 显示文摘Ottmann OG Wassmann B Pfeifer H 2007Cancer2007,109,10:1
5Rapid effect of 3-hydroxy-3-methyglutaryl coenzyme, a reduction inhibition,on ooronary endothelial function 显示文摘Wassmann S Faul A Hennen B 2003Circ Res2003,93,:1
6Rapid effect of 3 - hydroxy - 3 - methylglutaryl coenzyme, a re-ductase inhibition, on coronary endothelial funtion 显示文摘Wassmann S Faul A Hennen B 2003Circ Res2003,93,9:1
7HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species显示文摘Wassmann S Laufs U Bumer AT 2001Hypertension2001,37,6:1
8Therapy withimatinib mesylate (Glivec) preceding allogeneic stem celltransplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) 显示文摘Wassmann B Pfeifer H Scheuring U 2002Leukemia2002,16,12:1
9Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia ( Ph + ALL) 显示文摘Ottmann OG Wassmann B Pfeifer H 2007Cancer2007,109,10:1
10Rapid effect of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibition on coronary endothelial function显示文摘Wassmann S Faul A Hennen B 2003Circ Res2003,93,9:1
11Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme,a reductase inhibition,on coronary endothelial function显示文摘Wassmann S Faul A Hennen B 2003Circ Res2003,93,9:1
12Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia ( Ph + ALL) 显示文摘Ottmann OG Wassmann B Pfeifer H 2007Cancer2007,109,10:1
13Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) 显示文摘Wassmann B Pfeifer H Goekbuget N 2006Blood2006,108,5:1
14Rapid effect of 3-hydroxy 3-methylglul coenzyme a reductase inhibition on coronay endothelial function显示文摘Wassmann S Faul A Hennen B 2003Cire Res2003,93,9:1
15显示文摘Wassmann B Pfeifer H Scheuring U 2002Leukemia2002,,16:1
16Development of hygromas or severe edema during treatment with the tyrosine kinase inhibitor STI571 is not associated with platelet-derived growth factor receptor (PDGFR) gene polymorphisms显示文摘Brück P Wassmann B Lopez ER 2004Leuk Res2004,28,:1
17Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) 显示文摘Ottmann O G Wassmann B Pfeifer H 2007Cancer2007,109,10:1
18Early molecular response to posttransplantation imatinib determines outcome in MRD + Philadelphia-positive acute lympho- blastic leukemia ( Ph + ALL) 显示文摘Wassmann B Pfeifer H Stadler M 2005Blood2005,106,2:1
19Alternating versus concurrent schedules of Imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) 显示文摘Wassmann B Pfeifer H Goekbuget N 2006Blood2006,108,5:1
20Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib显示文摘Wassmann B Pfeifer H Scheuring U J 2004Blood2004,103,4:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费